Lactoferrin Suppresses Neutrophil Extracellular Traps Release in Inflammation  by Okubo, Koshu et al.
EBioMedicine 10 (2016) 204–215
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comResearch PaperLactoferrin Suppresses Neutrophil Extracellular Traps Release
in InﬂammationKoshu Okubo a,i,j, Mako Kamiya b, Yasuteru Urano b, Hiroshi Nishi c, Jan M. Herter c, Tanya Mayadas c,
Daigoro Hirohama a,h, Kazuo Suzuki d, Hiroshi Kawakami e, Mototsugu Tanaka a, Miho Kurosawa a,j,
Shinji Kagaya f, Keiichi Hishikawa g, Masaomi Nangaku a, Toshiro Fujita a,h,
Matsuhiko Hayashi i,j, Junichi Hirahashi a,i,j,⁎
a Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Japan
b Laboratory of Chemical Biology & Molecular Imaging, Graduate School of Medicine, The University of Tokyo, Japan
c Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, United States
d Inﬂammation Program, Graduate School of Medicine, Chiba University, Japan
e Division of Food and Nutrition, Graduate School of Human Sciences, Kyoritsu Women's University, Japan
f NRL Pharma, Inc., Japan
g Department of Advanced Nephrology and Regenerative Medicine, The University of Tokyo, Japan
h Research Center for Advanced Science and Technology, The University of Tokyo, Japan
i Apheresis and Dialysis Center, School of Medicine, Keio University, Japan
j Department of General Medicine, School of Medicine, Keio University, JapanAbbreviations: LLf, lactoferrin; NET, neutroph
myeloperoxidase; TRALI, transfusion-related acute lu
dendritic cells; ANCA, anti-neutrophil cytoplasmic a
erythematosus; PMA, phorbol 12-myristate 13-acetate
succinic anhydride; HOCl, hypochlorous acid; LPO, la
oxygen species; RPA, reverse passive Arthus.
⁎ Corresponding author at: Apheresis and Dialysis Ce
University, 35 Shinanomachi, Shinjuku, Tokyo 1608582, Ja
E-mail address: jhirahashi-tky@umin.ac.jp (J. Hirahash
http://dx.doi.org/10.1016/j.ebiom.2016.07.012
2352-3964/© 2016 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 29 May 2016
Received in revised form 10 July 2016
Accepted 12 July 2016
Available online 14 July 2016Neutrophils are central players in the innate immune system. They generate neutrophil extracellular traps
(NETs), which protect against invading pathogens but are also associated with the development of autoimmune
and/or inﬂammatory diseases and thrombosis. Here, we report that lactoferrin, one of the components of NETs,
translocated from the cytoplasm to the plasmamembrane andmarkedly suppressed NETs release. Furthermore,
exogenous lactoferrin shrunk the chromatinﬁbers found in releasedNETs,without affecting the generation of ox-
ygen radicals, but this failed after chemical removal of the positive charge of lactoferrin, suggesting that charge-
charge interactions between lactoferrin and NETs were required for this function. In a model of immune
complex-induced NET formation in vivo, intravenous lactoferrin injection markedly reduced the extent of NET
formation. These observations suggest that lactoferrin serves as an intrinsic inhibitor of NETs release into the cir-
culation. Thus, lactoferrin may represent a therapeutic lead for controlling NETs release in autoimmune and/or
inﬂammatory diseases.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Neutrophil migration to inﬂammatory sites and subsequent phago-
cytosis and intracellular elimination of microbes is essential for host de-
fense (Nathan, 2006). Activated neutrophils also release chromatin
ﬁbers called neutrophil extracellular traps (NETs), which trap and kill
bacteria (Brinkmann et al., 2004), tuberculosis pathogens (Ramos-il extracellular trap; MPO,
ng injury; pDC, plasmacytoid
ntibody; SLE, systemic lupus
; GA, glutaric anhydride; SA,
ctoperoxidase; ROS, reactive
nter, School of Medicine, Keio
pan.
i).
. This is an open access article underKichik et al., 2009), fungi (Urban et al., 2009), and parasites
(Guimarães-Costa et al., 2009). NETosis, the process of NET formation,
includes plasmamembrane rupture and chromatin ﬁber release follow-
ing the collapse of the nuclear membrane (Fuchs et al., 2007).
While NETs are beneﬁcial for host defense, their formation can also
be harmful. For example, in sepsis (Clark et al., 2007) and transfusion-
related acute lung injury (TRALI) (Caudrillier et al., 2012), NET forma-
tion induces damage to endothelial cells leading to massive thrombosis
in target organs such as the lungs and kidneys. NETsmay also serve as a
source of auto-antigens that activate plasmacytoid dendritic cells
(pDCs), thus triggering the activation of autoreactive B cells in the con-
text of autoimmune diseases (Lande et al., 2011). In systemic lupus er-
ythematosus (SLE), a reduction in NET degradation due to the
impaired functioning of DNase1 results in the progression of lupus ne-
phritis (Hakkim et al., 2010), and in autoimmune small-vessel vasculitis,
anti-neutrophil cytoplasmic antibody (ANCA) directly stimulatesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tion, the important role of NETs in the pathogenesis of atherosclerosis
has been reported (Knight et al., 2014; Döring et al., 2014).
Wepreviously studied themechanismof neutrophil-dependent vas-
culitis (Hirahashi et al., 2006) and glomerulonephritis (Hirahashi et al.,
2009) and found that activation of leucocyte β2 integrinMac-1 (CD11b/
CD18, CR3) is a critical determinant of disease activity and inﬂamma-
tion-induced thrombosis. Because NET formation requires Mac-1
activation and is a downstream effector for neutrophil-mediated cyto-
toxicity (Neeli et al., 2009), we hypothesized that a substance that safely
regulates NET formation may have applications in the treatment of in-
ﬂammatory diseases.
Lactoferrin (Lf), which is found mainly in human exocrine ﬂuids
(such as maternal milk or tears) and speciﬁc granules (secondary gran-
ules) of human neutrophils (Broxmeyer et al., 1978), exhibits antibacte-
rial properties (Pütsep et al., 2002) and possesses a strong positive
charge. In addition to DNAand histones, NET ﬁbers contain extranuclear
proteins and proteins such as elastase, myeloperoxidase (MPO),
and Lf, which are components of neutrophil granules (Urban et al.,
2009). Although elastase and MPO are essential for NET formation
(Papayannopoulos et al., 2010), the biological signiﬁcance of Lf remains
unclear.
In this study, we investigated the contribution of Lf to NET formation
during inﬂammation. We developed a real-time cell imaging system
using confocal ﬂuorescence microscopy that can be used to visualize
neutrophil activation, DNA and cell membrane structures by utilizing
our original probes for reactive oxygen species in the cells. Here, we
identiﬁed Lf as an intrinsic inhibitor of NETs release and a promising
therapeutic target in pathological conditions related to NETs.
2. Materials and Methods
2.1. Isolation of Neutrophils and Platelets
Human peripheral blood samples (15 mL) were obtained from
healthy volunteers who were not taking any regular medication. Neu-
trophils were isolated usingMono-Poly ResolvingMedium (DS Pharma
Biomedical, Japan) from whole blood collected in EDTA. Neutrophils
were suspended in culture medium containing DMEM supplemented
with 2% heat-inactivated human serum albumin (Sigma-Aldrich, St.
Louis, MO, USA) and 4mM L-glutamine (Sigma-Aldrich) at 8 °C. Cell pu-
rity (N95%)was conﬁrmed byGiemsa staining. Plateletswere isolated at
room temperature according to previously published methods (Müller
et al., 2003). All procedures were conducted with permission from the
medical ethics committee of The University of Tokyo, Japan.
2.2. Analysis of NET Formation
Neutrophils were seeded at 1 × 105 cells/well in μ-Slide 8-well plates
(Ibidi, Germany) and incubated for 30 min with 2–200 μg/mL Lf from
human neutrophils (Sigma-Aldrich) or bovine milk (Sigma-Aldrich),
200 μg/mL angiogenin, 200 μg/mL lactoperoxidase, 200 μg/mL G-Lf,
200 μg/mL S-Lf (generated as described for the charge-conversion of
Lf), 10 μM diphenyleneiodonium chloride (DPI; Sigma-Aldrich) as an
NADPH oxidase inhibitor, 1 mM 3-amino1,2,4,triazole (3AT; Wako,
Japan) as a catalase inhibitor, 200 U/mL catalase (Sigma-Aldrich),
5 ng/mL recombinant human tumor necrosis factor alpha (TNFα; R&D
Systems) and/or 200 μg/mL transferrin (Wako), and 10 U/mL heparin
as a negatively charged molecule. Neutrophils were then stimulated
with 12.5–25 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Al-
drich) for 3 h, 5 μg/mL monoclonal antibodies targeting MPO (MPO-
ANCA, Acris Antibodies, USA, Cat# SM1475P RRID:AB_1005506) for
3 h, and 5 × 106 platelets (for 5 × 105 neutrophils) for 1 h. For live cell
imaging, neutrophils were incubated with 500 nM SYTOX Green
(Invitrogen/Life Technologies), 5 μM DRAQ5 (Abcam) for staining
DNA, 500 nM HySOx for probing hypochlorous acid (HOCl), and/or5 μg/mLWGA (Invitrogen/Life Technologies) for staining the cell mem-
brane. Confocal ﬂuorescence microscopy (Leica SP-5) was used to visu-
alize NET formation at 37 °C. The ﬂuorescence intensities of SYTOX
Green, HySOx- and tetramethylrhodamine-labeled WGA, and DRAQ5
were determined at 500–540, 560–620, and 650–750 nm, respectively,
with excitation at 490, 550, and 630 nm, respectively. For quantiﬁcation
of NET formation, we counted the number of cells that released SYTOX
Green ﬂuorescence into the extracellular space by reference to the re-
port by Brinkmann et al. (2010) and divided this number by the total
number of cells in the same ﬁeld. Furthermore, we used Picogreen
dsDNA assay reagent to quantify NET-DNA from 1 × 105 cells per
400 μL culture medium. Activated platelet-induced NET formation was
evaluated as previously described (Clark et al., 2007). Brieﬂy, 5 × 105
neutrophils were pretreated with 10 μM SQ29548 (Santa Cruz Biotech-
nology; a selective thromboxane receptor antagonist) for 10 min and
200 μg/mL Lf for 30min before stimulation. Plateletswere pre-activated
with or without 50 μM thrombin receptor-activating peptide (TRAP, a
PAR-1 agonist; Sigma-Aldrich) for 30 min and incubated with neutro-
phils for 1 h at 37 °C. Soluble IC-induced NETosis was evaluated as pre-
viously described (Chen et al., 2012). For preparation of soluble ICs, BSA
and anti-BSA antibodiesweremixed at 4–6 times antigen excess and in-
cubated at 37 °C overnight as previously described (Stokol et al., 2004).
For each experiment, the measured values were averaged from three
replicates after the background was subtracted.
2.3. Analysis of NETs in Reverse Passive Arthus (RPA) Reaction In Vivo
Analysis of NET-like structures was performed as described previ-
ously (Chen et al., 2012). Brieﬂy, male eight-week-old WT C57BL6/j
mice were treated with 20 mg/kg bovine Lf or PBS alone, followed by
administration of an intrascrotal injection of anti-BSA antibodies
(200 μg/300 μL, Sigma-Aldrich) and an intravenous injection of BSA
(300 μg/100 μL, Sigma-Aldrich) to induce RPA reaction as previously re-
ported (Stokol et al., 2004). After 3 h, mice were injected with SYTOX
Green (25 nM, Molecular Probes, USA), and the cremaster muscle was
prepared for intravital microscopy. Images were obtained using an up-
right epiﬂuorescence microscope (FV1000, Olympus Imaging, USA)
with a 40× water-immersion objective. Images were recorded with a
CCD camera (DP72, Olympus Imaging) and analyzed using ImageJ soft-
ware (NIH). SYTOX Green-positive individual NET ﬁbers were counted
in 8–10 representative images (436 μm × 328 μm). Data are presented
as the average number of ﬁbers (±standard error of the mean
[s.e.m.]) per mm2. Signals from intact SYTOX Green-positive cells were
excluded from this analysis, and only those exceeding 20 μm in length
were considered NET-like formations. The number of neutrophils was
quantiﬁed using reﬂected light oblique transillumination in the area
75 μm to each side of the vessel over a 100-μm vessel length
(1.5 × 10−4 mm2).
2.4. Immunoﬂuorescence Microscopy
Neutrophils (1 × 105) were stimulatedwith 25 nMPMA in the pres-
ence or absence of 200 μg/mL Lf and ﬁxed on microslide glass
(Matsunami, Japan) using cytospin. Neutrophils were ﬁxed with 4%
paraformaldehyde and blocked with 3% BSA (Sigma-Aldrich) for 1 h
and incubated for 1 h at room temperaturewith ﬂuorescently conjugat-
ed anti-lactoferrin antibodies (1:100, HyTest Ltd., Finland, Cat# 4L2-2B8
RRID:AB_1618690) labeled with Alexa 488 SE (Invitrogen/Life Technol-
ogies), anti-elastase antibodies (1:200, Calbiochem/Merck Millipore,
Germany, Cat# 481001, RRID:AB_212213) labeled with Alexa Fluor
546 (Invitrogen/Life Technologies), or DRAQ5 for staining DNA or with
5 μg/mL WGA for staining cell membranes. A ﬂuorescence microscope
(Leica SP-5) equipped with Z-axis imaging and DIC was used to collect
images. We used ImageJ processing software to normalize and quantify
the signals of Lf relative to those of the background.
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HL-60 cells (ATCC, USA, Cat# CCL-240, RRID:CVCL_0002) were incu-
bated with IMDM (ATCC) containing 20% fetal bovine serum (FBS;
ATCC) and antibiotics at 37 °C. HL-60 cells were then incubated with
1.25% dimethyl sulfoxide (DMSO; ATCC) for 3 days to differentiate HL-
60 granulocytes. Transfection of HL-60 cells with lactoferrin siRNA
was performed according to the manufacturer's instructions (Qiagen,
Germany). To verify knockdown of Lf mRNA, we puriﬁed RNA using
RNeasy (Qiagen) and used this RNA to synthesize cDNA with High Ca-
pacity RNA-to-cDNA Master Mix (Applied Biosystems/Life Technolo-
gies, USA). We analyzed the comparative threshold cycles (CTs) to
determine gene expression with a Step One Plus Real-Time PCR system
(Applied Biosystems/Life Technologies) using TaqMan Gene Expression
MasterMix (TaqMan/Life Technologies) and the following 6-carboxyﬂu-
orescein (FAM)-labeled primers: LTF, TCTGGTGCCTTCAAGTGTCTGAGAG
or GAPDH, CAAGAGGAAGAGAGAGACCCTCACT. Reactions were per-
formed under the following conditions: 50 °C for 2 min, 95 °C for
10 min as a holding step, and 40 cycles of 95 °C for 15 s and 60 °C for
1 min. To quantify NET-DNA, 1 × 105 HL-60 cells were resuspended in
400 μL culture medium and stimulated with 25 nM PMA. DNA concen-
trations in the culture medium were measured using Picogreen dsDNA
assay reagent at 3 h after PMA stimulation.
2.6. Electron Microscopy
Neutrophils (1 × 106) pretreated with or without 200 μg/mL
lactoferrin for 30 min were stimulated with 25 nM PMA and incubated
for 3 h at 37 °C. Freshly puriﬁed neutrophils were allowed to adhere to
glass coverslips in culture medium. Neutrophils were then ﬁxed in
0.1 M phosphate buffer (pH 7.4) containing 2% glutaraldehyde at 4 °C
and postﬁxed in 2% OsO4 in 0.1 M phosphate buffer (pH 7.4) for 1 h.
Samples were dehydrated through a graded ethanol series, placed in
propyleneoxide, and embedded in epoxy resin (Quetol 812). Ultrathin
sections made with a Leica EM UCT ultramicrotome were stained with
2% uranyl acetate in distilled water for 15 min following by modiﬁed
Sato's lead solution for 5 min. Grids were viewed with a JEM-1200EX
transmission electron microscope (TEM; JEOL, Japan) operating at
80 kV.
For scanning electron microscope (SEM) analysis, neutrophils were
ﬁxed in 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) at 4 °C
and further ﬁxed in 2% OsO4 in 0.1 M phosphate buffer at 4 °C for 1 h.
Samples were then dehydrated in ethanol, placed in isoamyl acetate,
critical-point dried, coated with a layer of sublimated OsO4 using an os-
mium plasma coater (OPC80N; Filgen, Nagoya, Japan), and examined
using an SEM (JSM-6320F; JEOL).
2.7. Electrophoresis of NETs
Electrophoresis of NETs was performed as described previously
(Nakazawa et al., 2012). Brieﬂy, 1 × 107 neutrophils were stimulated
with 25 nM PMA at 37 °C. At 3 h after stimulation, we centrifuged sam-
ples and extracted DNA from Netting neutrophils (NET-DNA) into TE
buffer using a DNA Extractor SP Kit (Wako). The extracted NET-DNA
was incubated with 200 μg/mL Lf, G-Lf, S-Lf, 10 U/mL heparin (Sigma-
Aldrich), 1 mg/mL lipopolysaccharide, and 1 U/mL DNase 1 (Roche Di-
agnostics, Germany) for 1 h at 37 °C. Sampleswere separated on 1% aga-
rose gels at 5× 104 neutrophils/lane and stainedwith ethidiumbromide
to illuminate under UV light.
2.8. Charge-Conversion of Lactoferrin
Alkylation of ε-amine of lysine with glutaric anhydride (GA) and
succinic anhydride (SA) was performed as follows. Brieﬂy, 0.5 mg of
human lactoferrinwas dissolved in 1mL PBS(−) at pH 9.5. The solution
was stirred at 0 °C for 30 min, and 2.85 mg GA or 2.5 mg SA was added.After stirring on ice for 2 h, the mixture was puriﬁed with PD MidiTrap
G-25 (GE Healthcare UK Ltd, UK) according to the gravity protocol
(Goda and Miyahara, 2010).
2.9. Preparation of Basic and Acidic Peptides of Lactoferrin
After acidiﬁcation with hydrochloric acid to pH 2.5, a 5% (w/v) solu-
tion of bovine Lf in water was incubated with pepsin (E/S = 1/50) for
5 h at 37 °C. The hydrolysis was stopped by adjusting the pH to 7.0
using sodium hydroxide. The basic peptide of Lf was isolated using an
ACTA Explorer 10S chromatography system equipped with a cation-ex-
change resinMono S HR 5/5 column (GEHealthcare). The elution gradi-
ent was 2 M sodium chloride in 20 mM sodium phosphate buffer
(pH 7.0) to remove impurities and undigested Lf, and 2 M ammonium
chloride in 20 mM sodium phosphate buffer (pH 7.0) for elution of
the basic peptide of Lf. The acidic peptide of Lf was chemically synthe-
sized by the F-moc (ﬂuorenylmethoxycarbonyl) method using a pep-
tide synthesizer Model 433A (Applied Biosystems). The amino acid
sequence of the peptides was analyzed using a peptide sequencer
PPSQ-21A (Shimadzu).
2.10. Statistics
A survival graph was created using the Kaplan-Meier method. Sur-
vival curves were compared by the log-rank test. Data are expressed
as means ± s.e.m. In all cases, unpaired t tests were used to compare
two groups. Differences with P values of b0.05 were considered signiﬁ-
cant. All statistical analyseswere performed using JMP 10 software (SAS
Institute Inc., Cary, NC, USA).
3. Results
3.1. Lactoferrin Inhibited NET Formation In Vitro
As previously described, human neutrophils were stimulated with
PMA and soluble immune complexes (ICs) (Chen et al., 2012), ANCA
(Kessenbrock et al., 2009), and activated platelets (Caudrillier et al.,
2012) to induce NET formation. DPI, an NADPH oxidase inhibitor that
inhibits NET formation by decreasing the generation of reactive oxygen
species (ROS), blockedNET formation, consistentwith a previous report
(Fuchs et al., 2007). Lf inhibited NETs release (Movie S1A and S1B) in a
dose-dependent manner as assessed by microscopy (Fig. 1a and b), and
blocked DNA release in the culture medium (Fig. 1c) in cells stimulated
with ICs (Fig. 1d), ANCA (Fig. 1e, Movie S2A and S2B), and activated
platelets (Fig. 1f). In contrast, transferrin showed no effect (Fig. S1).
Moreover, DNA release was signiﬁcantly inhibited by Lf treatment, at
even 1 and 2 h after stimulation (Fig. 1g), suggesting that Lf affected
the later mechanisms of NET formation. SEM revealed that Lf dramati-
cally changed the morphological characteristics of NETs. While individ-
ual NET ﬁbers were observed without Lf, Lf treatment led to the
formation of agglutinated ﬁbers (Fig. 1h), suggesting that Lf prevented
the spread of NETs and their release into circulation.
3.2. Lactoferrin Inhibited Immune Complex-Induced NET Formation in a
Model of RPA Reaction
We examined the effects of Lf on the skin RPA reaction, a model of
Type III hypersensitivity elicited by the intravenous injection of BSA
and the local injection of anti-BSA. FcγRIIA in human neutrophils in-
duces NET formation independent of elastase,MPO, and oxygen radicals
in vivo. Microscopic analysis showed that intravenous injection of Lf led
to a reduction in SYTOX Green-positive NET ﬁbers (Fig. 1i), and quanti-
ﬁcation of NET formation conﬁrmed that the number of neutrophils did
not differ signiﬁcantly between treatment conditions (Fig. 1j).
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Citrullination During NETosis
Since ROS generation plays an important role during NETosis (Fuchs
et al., 2007), we evaluated whether Lf affected this process. Neutrophils
were incubated with HPF (a ﬂuorescence probe for ROS) or HySOx (a
ﬂuorescence probe for HOCl) for analysis of ROS generation in living
cells (Kenmoku et al., 2007; Setsukinai et al., 2003). Fluorescence inten-
sity of the ROS probesmeasured by ﬂow cytometry increased in a time-
dependentmanner during NETosis (Fig. 2a, b, d, and e). Lf had no effect,
while DPI signiﬁcantly decreased the ﬂuorescence intensities of these
ROS probes (Fig. 2c and f). Live-cell imaging also demonstrated HOCl
production in the presence of Lf (Movie S1A and S1B). Catalase, which
catalyzes the breakdown of hydrogen peroxide, is known to inhibit
NET formation (Fuchs et al., 2007). To test whether Lf suppressed NET
formation by enhancing catalase activity, neutrophils were pretreated
with catalase. DNA concentration in the supernatant was signiﬁcantly
reduced by catalase, which was reversed by 3AT, a catalase inhibitor.
Lf signiﬁcantly reduced the DNA concentration, even in the presence
of 3AT (Fig. 2g), indicating that Lf inhibitedNET formation independent-
ly of catalase. Histone H3 citrullination, catalyzed by the enzyme
peptidyl arginine deiminase 4 (PAD4), is thought to be essential for
NET formation (Li et al., 2010). In our experimental system, histone
H3 citrullinationwas completely inhibited by DPI, but was not inhibited
by Lf (Fig. 2h). Autophagy may be important in NET formation, and
vacuolization is one of morphological features of autophagy (Remijsen
et al., 2011). In our system, massive vacuolization was observed in
stimulated neutrophils, regardless of Lf treatment, as assessed by TEM
(Fig. 2i), supporting that Lf inhibited NET formation independent of
autophagy.
3.4. The Sequences of Basic Amino Acids in Lactoferrin and Charge-Charge
Interactions With NET-DNA Were Important for Inhibition of NET
Formation
Lf is known to bind DNA via interactions of positively charged resi-
dues in the N-terminal of Lf with negatively charged DNA (He and
Furmanski, 1995). We tested whether Lf directly bound to NETs via
charge-charge interactions. NET-DNA (Fig. 3a) and calf thymus DNA
(Fig. 3b) bands shifted upwards following treatment with Lf; this effect
was negated by the addition of negatively charged molecules such as
heparin or lipopolysaccharide, suggesting that Lf directly bound to
NET-DNA via charge-charge interactions. We conﬁrmed that the
bands that shifted upwards were degraded by DNase1 treatment (Fig.
S2A and B). To investigate whether the positive charge of Lf was a crit-
ical factor required for the inhibition of NET formation, we generated
charge-converted Lf by employing site-selective chemical modiﬁcations
of positive amino acid side chains using conventional acylation and
glycation reactionswithGA and SA (Goda andMiyahara, 2010).We suc-
cessfully obtained Lfmodiﬁed by GA (G-Lf) and SA (S-Lf), as assessed by
Western blot analysis using anti-Lf antibodies (Fig. S2C). We conﬁrmed
that newly obtained Lf failed to bind to NET-DNA (Fig. S2D), indicating
that the positive charge of Lf was lost. G-Lf and S-Lf failed to inhibit
NET formation (Fig. 3c,Movie S3A and S3B), suggesting that the positive
charge of Lf was required to inhibit NET formation. Next, we testedFig. 1. Lactoferrhgin inhibited NET formation both in vitro and in vivo. (a) Cells
formation was induced by 25 nM PMA. NET formation was measured by microscopy at 3 h
⁎⁎P b 0.01, ⁎⁎⁎P b 0.001. (b) Images of neutrophils pretreated with 200 μg/mL lactoferrin at 3
bars: 40 μm. NET-DNA release into supernatants induced by PMA (c), soluble IC (d), MPO-A
Each group: n = 3,⁎P b 0.05, ⁎⁎P b 0.01, ⁎⁎⁎P b 0.001, †P b 0.05, ††P b 0.001, ‡P b 0.05. (g) NET
group: n = 3, **P b 0.01. (h) Scanning electron microscopy revealed dramatic morphologi
lactoferrin treatment (second left); agglutinated NET ﬁbers in the presence of exogenous lact
structures were visualized using intravital microscopy. Representative images of animals treat
of NET-like structures per mm2 in the cremaster 3 h after induction of the RPA reaction w
different between groups. Data are representative of the means ± SEMs of three experiments.angiogenin (molecular weight [MW]: 14.6 kDa; isoelectric point [pI]:
9.5), a known tumor angiogenic factor (Fett et al., 1985) and
lactoperoxidase (LPO; MW: 80.6 kDa; pI: 8.0), a heme peroxidase with
MWsimilar to Lf and abundant inmilk (Sharma et al., 2013), to evaluate
the effects of positively-chargedmolecules on NET formation. Both pro-
teins failed to inhibit NET formation (Fig. 3d), suggesting that positive
charge alone was not sufﬁcient to suppress this process. Furthermore,
we neutralized the positive charge of Lf by adding negatively charged
heparin into the culture medium. Interestingly, NETs release was dra-
matically enhanced and widespread, even in the presence of Lf
(Fig. 3e, Movie S4A and S4B), conﬁrming our hypothesis that the posi-
tive charge of Lfwas vital to the inhibition of NETs release. Next, we pre-
pared basic and acidic peptides derived from bovine Lf and analyzed
effects of these peptides onNET formation. Basic peptides of Lf inhibited
NET formation, while acidic peptides did not (Fig. 3f), suggesting that
basic peptides, positively charged sequences of only 25 amino acids
(Fig. S3), were the main molecules contributing to the inhibition of
NET formation.
3.5. Silencing Lactoferrin Enhanced NET Formation in HL-60 Cells
To study the role of endogenous Lf on NET formation, we knocked
down Lf mRNA in the neutrophil-like human myeloid leukemia cell
line, HL-60 using small-interference RNA (siRNA) and induced NET for-
mation (Li et al., 2010). The expression of Lf mRNA and protein in-
creased after differentiation of the cells (Fig. 4a and b) and decreased
in Lf siRNA-transfected cells by 54% and 49%, respectively (Fig. 4c and
d). When HL-60 granulocytes were stimulated with PMA, the concen-
tration of extracellular DNA in the supernatant was 2.2-fold higher in
cells transfected with Lf siRNA than in cells transfected with control
siRNA (Fig. 4e). These data indicate that Lf serves as an endogenous in-
hibitor of NETs.
3.6. Lactoferrin Localized to the Plasma Cell Membrane During NETosis
We examined the distribution of endogenous Lf, elastase, and DNA
during NETosis using immunoﬂuorescence microscopy (Fig. 5a, c, and
d). Both, Lf and elastase were present in the cytoplasm of unstimulated
neutrophils (Fig. 5a and c). After a 2-h PMA stimulation, Lf localized to
the cell membrane (Fig. 5d). Moreover, exogenous human Lf added to
the culturemediumalso localized to the cellmembrane of unstimulated
and PMA-stimulated cells (Fig. 5b and e), and protected against
spreading of NETs (Movie S5A and S5B, Fig. S6). Web-like DNA struc-
tures were observed in most cells after 3 h and were positive for Lf
and DNA (Fig. 5f). Thus, the localization of Lf on the cell membrane dur-
ing NETosis suggested that Lf interacts with NETs just before rupture of
the cell membrane.
3.7. Lactoferrin Did Not Suppress the Translocation of Elastase to the Nucle-
us or Elastase-Mediated Degradation of Histones
During NETosis, neutrophil elastase escapes from granules and
translocates to the nucleus, where it degrades histones and promotes
chromatin decondensation (Papayannopoulos et al., 2010).We evaluat-
edwhether this processwas altered in the presence of Lf.We found thatwere pretreated with different concentrations of human lactoferrin, and NET
after PMA stimulation. DPI (10 μM) was used as a positive control. Each group: n = 3,
h after stimulation. Cells were stained with 500 nM SYTOX Green to detect DNA. Scale
NCA (e), or activated platelets (f) in response to different concentrations of lactoferrin.
-DNA release was measured at various times in response to 200 μg/mL lactoferrin. Each
cal changes induced by lactoferrin treatment. Individual NET ﬁbers observed without
oferrin (right panels). Scale bars: 5 μm (left panels), 40 μm (right panels). (i, j) NET-like
ed with PBS (lower panel) or bovine lactoferrin (upper panel) are shown (i). The number
as quantiﬁed (j). ⁎P b 0.05. The number of neutrophils (#Neuts) was not signiﬁcantly
Fig. 2. Lactoferrin did not decrease ROS generation or histone H3 citrullination during NETosis. (a–g) Effects of lactoferrin on ROS generation, (h) histone H3 citrullination, and
(i) vacuolization during NETosis. The ﬂuorescence intensities of HySOx (a–c) and HPF (d–f) added to the culture medium 30 min before PMA stimulation were measured at the
indicated times (b, e) or at 1 h (a, c, d, f). Each group: n = 3, ⁎⁎P b 0.01, ⁎⁎⁎P b 0.001. (g) DNA release into the supernatant was induced with 12.5 nM PMA and was measured in the
presence of catalase, lactoferrin, and/or, 3AT. Each group: n = 3, ⁎⁎⁎P b 0.001, †P b 0.001. (h) Western blot analysis was used to investigate PMA-induced histone H3 citrullination in
response to DPI and lactoferrin treatment. Figures are representative of two independent experiments. (i) Transmission electron microscopy analysis of vacuolization in PMA-
stimulated neutrophils. Figures are representative of two independent experiments. Scale bars: 2 μm. Data represent the mean ± SEM.
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tion of elastin (Fig. 6a). Translocation of elastase to the nucleus in stim-
ulated neutrophils was also observed in the presence of Lf (Fig. 6b).
Moreover,Western blot analysis revealed that Lf did not inhibit the elas-
tase-mediated degradation of recombinant histones H1 and H4
(Fig. 6c). Furthermore, histones H2B, H3, and H4 in the neutrophils
were degraded upon PMA stimulation, and these degradation events
were not inhibited by Lf treatment (Fig. 6c).
4. Discussion
In this study, we found that Lf inhibited NET formation without af-
fecting ROS generation, PAD4-dependent histone H3 citrullination, orelastase-mediated histone degradation, which are accomplishedwithin
a fewminutes, 1 h, and 2 h, respectively (Parker et al., 2012), but instead
affected the later stages of NETosis.
We have previously screened the naturally derived substances that
improved survival rates in Spontaneously Crescentic Glomerulonephri-
tis/Kinjoh (SCG/kj) mice (Kinjoh et al., 1993), which are recombinant
congenicmice that develop rapidly progressive renal failurewith hema-
turia, MPO-ANCA production that resembles rapidly progressive glo-
merulonephritis (RPGN) in humans, and ANCA-associated vasculitis
(AAV). We previously reported that one of these substances,
eicosapentaenoic acid, has potential as a therapeutic agent for autoim-
mune small-vessel vasculitis (Hirahashi et al., 2014). In this study, we
describe that Lf as another candidate. Going further, we have begun
Fig. 3. Lactoferrin bound NET-DNA and inhibited NET formation via charge-charge interactions. NET-DNA extracted from human neutrophils (a) and calf thymus DNA (b) treated with or
without lactoferrin was analyzed by electrophoresis using 1% agarose gels. NET-DNA release into the supernatants induced by PMA in response to 200 μg/mL of lactoferrin, G-Lf, and S-Lf
(c), angiogenin and LPO (d), 10 U/mL heparin (e), or acidic or basic peptides of lactoferrin (f). Each group: n = 3, ⁎P b 0.05, ⁎⁎P b 0.01, ⁎⁎⁎P b 0.001. Data are representative of three
independent experiments.
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Lf in AAV and hypothesize that Lf affects NET formation,which is closely
associated with pathology of AAV.
Current knowledge indicates that Lf binds to DNA and contains pos-
itively charged residues at the N-terminal; this peptide is known as
lactoferricin B (Britigan et al., 2001). In this study, using chemical mod-
iﬁcation methods, we showed that Lf binds to NETs via charge-charge
interactions, which likely occur just before NETs release. Additionally,
from our data, we propose that positively charged sequences of 25
aminoacids in Lf are the keymolecules inhibitingNET formation. In sup-
port of this, previous studies have demonstrated that NETs can be
cleared via binding to nanomaterials (Bartneck et al., 2009), with the
positive charge signiﬁcantly enhancing particle trapping.
Activated platelets have been shown to induce NET formation (Clark
et al., 2007) and are closely associated with the pathogenesis of deep
vein thrombosis (von Brühl et al., 2012). We found that Lf inhibited ac-
tivated platelet-induced NET formation in vitro, suggesting that Lf mayhave applications in the management of thrombosis. A recent study
has deﬁned the process of immunothrombosis as an innate immunity
mechanism, to which NETs contribute (Engelmann and Massberg,
2012). The major components of NETs, i.e., DNA and histones, activate
factor XII of the intrinsic coagulation pathwaydirectly via the negatively
charged surfaces of the nucleic acids and induce platelet aggregation
(Chen et al., 2014; Andrews et al., 2014; Fuchs et al., 2011; Fuchs et al.,
2010). Dysregulation of immunothrombosis leads to pathological vas-
cular obstructions in inﬂammatory diseases. In this context, Lf may be
able to properly regulate immunothrombosis by suppressing overpro-
duction of NETs.
Several previous reports have demonstrated that heparin interferes
with the formation of NET by disrupting the histone backbone of NET
structure (Fuchs et al., 2010, 2011). We observed that the spread of
NET structure is exaggerated in the presence of heparin, which cancels
the inhibitory effect of Lf by charge-charge interaction. On the other
hand, Schauer et al. demonstrated that aggregated NETs (aggNETs)
Fig. 4. Silencing of lactoferrin expression enhanced NET formation in HL-60 cells. (a, b) Conﬁrmation of lactoferrin knockdown by siRNA after differentiation of HL-60 cells. (a) Lactoferrin
mRNA was measured by real-time PCR after differentiation with 1.25% DMSO. Each group: n = 6, ⁎⁎P b 0.01. (b) Lactoferrin protein levels were measured by Western blot analysis
(membrane image: upper panel; quantiﬁcation of lactoferrin protein normalized to β-actin expression: lower panel. Each group n = 3, ⁎P b 0.05). (c, d) Silencing of lactoferrin by
siRNA transfection. (c) Lactoferrin mRNA and (d) protein expression were measured in cells transfected with lactoferrin siRNA (membrane image: upper panel; quantiﬁcation of
lactoferrin protein normalized to β-actin expression: lower panel). Each group: n = 5 (c), n = 3 (d), ⁎⁎P b 0.01. (e) The concentration of extracellular DNA in the supernatant was
measured following transfection with lactoferrin siRNA. Each group: n= 3, ⁎⁎P b 0.01. Data are representative of the means ± SEMs of three experiments.
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gout model of synovium inﬂammation (Schauer et al., 2014). Taken to-
gether, oppositely charged heparin and Lf act differently on the NET
structure, but both substances could play beneﬁcial roles by modiﬁca-
tion of the harmful structure of NETs.
Although our data suggest that Lf is an endogenous inhibitor of NETs,
neutrophils that store Lf still produce NETs. Importantly, Lf is found on
NET-ﬁbers (Urban et al., 2009, and our immunoﬂuorescence image).
Thus, excess production of NETs (providingmuchmore Lf release) pos-
sibly downregulates further NETosis, as observed in patients of familial
Mediterranean fever (Apostolidou et al., 2016).
We propose the mechanism of action of Lf during NET formation
(Fig. 7). We hypothesize that endogenous Lf may inhibit NET formationbut is insufﬁcient to block excess NETs in pathological conditions. In
support of this, the activity of rheumatoid arthritis correlates with
anti-Lf antibody titers (Kida et al., 2011), and high levels of anti-Lf anti-
bodies in SLE patients are associated with clinical manifestations of SLE
(Caccavo et al., 2005). These reports suggest that impairment of Lf activ-
ity by anti-Lf antibodiesmay be the cause of inﬂammatory pathogenesis.
In this regard, supplying exogenous Lfmay have signiﬁcant implications
in controlling disease activities.
NET formation can be inhibited by blocking the Raf-MEK-ERK path-
way (upstream of NADPH oxidase), making this pathway a potential
target of NET inhibitors (Hakkim et al., 2011). In TRALI, platelets are as-
sociatedwithNET formation and aspirin suppresses disease progression
by decreasing platelet activation (Caudrillier et al., 2012), thereby
Fig. 5. Lactoferrfebcain localized to the plasma cell membrane during NETosis. (a, c, d) Representative images acquired using immunoﬂuorescence staining of endogenous lactoferrin
(green), elastase (red), and DNA (blue) are shown. Both lactoferrin and elastase existed in the cytoplasm of unstimulated neutrophils at 0 h (a) and 2 h (c). (d) Following 2 h of PMA
stimulation, lactoferrin localized to the plasma cell membrane. Exogenous lactoferrin added to the culture medium localized to the plasma cell membrane at 0 h (b) and 2 h (e). Scale
bars: 5 μm. (f) Web-like DNA structures were positive for lactoferrin (green) and DNA (blue) at 3 h. Scale bar: 10 μm. Data are representative of two independent experiments.
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rine lupus by inhibiting NET formation (Knight et al., 2013). However,
endogenous substances that are safe and efﬁcacious NET inhibitors
have not yet been reported; our results suggest that Lf can be considered
as a candidate endogenous antagonist of NETs. However, since forma-
tion of NETs is one of the important mechanisms of innate immunity
in neutrophils, inhibiting NET formation may cause susceptibility toinfection. However, previous reports have shown that Lf itself exhibits
microbicidal activity by virtue of its iron chelating ability (Weinberg,
1984; Bellamy et al., 1992). Additionally, Lf has been shown to improve
survival rates, even in septic patients (Manzoni et al., 2009).
Some limitations and caveats apply to the ﬁndings of this study.
These include the lack of stabilitywhen Lf is administered in clinical set-
tings. A lactoferrin-derived peptide with smaller molecules that is as
Fig. 6. Lactoferrin did not suppress the translocation of elastase into the nucleus or elastase-mediated degradation of histones. (a) The ﬂuorescence intensity released from labeled-elastin
degraded by elastasewas evaluated as ameasure of elastase activity. Theﬁgure is representative of three independent experiments. (b) Neutrophils pretreatedwith orwithout lactoferrin
were observed by confocalmicroscopy stained for elastase (red) or DNA (blue), or observed as differential interference contrast (DIC) imageswith Z-axis imaging (lower panel) after 2 h of
stimulation with PMA. Scale bars: 5 μm. Figures are representative of two independent experiments. (c) Recombinant human histone H1 and H4 pretreated with or without lactoferrin
were treated with human elastase. Western blotting analysis was performed as described in the Methods (upper panels). Neutrophils were stimulated with PMA in the presence or
absence of lactoferrin using anti-histone H2B, H3, and H4 antibodies (lower panels). Figures are representative of two independent experiments.
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application.
In conclusion,we found that Lf inhibits the formation of NETs, poten-
tially by preventing the spread of NETs via charge-charge interactions;
these results have implications in the development of new and safe clin-
ical options to control diseases associatedwithNETs. Further studies are
required to elucidate the mechanisms of Lf-dependent regulation of
NET formation.5. Study Approval
All animal experiments were carried out following ARRIVE standard
in accordance with procedures approved by the Animal Experimental
Committee of the Graduate School of Medicine, The University of
Tokyo, Japan.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.07.012.
Fig. 7. Proposedmechanism of action of lactoferrin during NET formation.We found that lactoferrin inhibited NET formation induced by various stimulants, such as PMA,MPO-ANCA, and
activated platelets. Lactoferrin had no effect on intracellular pathways, such as elastase-mediated degradation of histones or histone citrullination catalyzed by PAD4 following ROS
generation. Furthermore, lactoferrin also inhibited soluble IC-induced NET formation, which was independent of ROS generation. Our proposed mechanism showed that lactoferrin
prevented the spread of NETs and their release by blocking membrane rupture and causing agglutination of the released chromatin ﬁbers. This ﬁgure was produced using Illustrator
CC (Adobe Systems Incorporated, USA).
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